How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
Multiple myeloma (MM) is a B-cell malignancy characterized by clonal proliferation of malignant plasma cells in the bone marrow, monoclonal protein production in the serum, and organ dysfunction. It is part of a disease spectrum called plasma cell disorders, and to establish the diagnosis, a bone ma...
Saved in:
Main Authors: | Wulyo Rajabto, Dimas Priantono |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2022-09-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/2029 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01) -
Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01) -
Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01) -
Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)